|
Three Months Ended |
|
Years Ended |
||||||||||||
|
December 31, |
|
December 31, |
||||||||||||
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Stock-based compensation |
|
|
|
|
|
||||||||||
Cost of sales |
$ |
979 |
|
$ |
887 |
|
|
$ |
3,766 |
|
$ |
3,475 |
|
||
Sales and marketing |
5,462 |
|
4,868 |
|
|
22,288 |
|
19,612 |
|
||||||
Research and development |
5,129 |
|
4,236 |
|
|
17,769 |
|
16,265 |
|
||||||
General and administrative |
4,251 |
|
3,393 |
|
|
14,552 |
|
12,086 |
|
||||||
Provision for income taxes |
(445) |
|
(1,433) |
|
|
(8,705) |
|
(9,337) |
|
||||||
Total |
$ |
15,376 |
|
$ |
11,951 |
|
|
$ |
49,670 |
|
$ |
42,101 |
|
||
|
|
|
|
|
|
||||||||||
Amortization of acquisition-related intangibles and fair value adjustments |
|
|
|
|
|
||||||||||
Net sales |
$ |
1,961 |
|
$ |
— |
|
|
$ |
3,260 |
|
$ |
— |
|
||
Cost of sales |
4,313 |
|
823 |
|
|
9,892 |
|
3,348 |
|
||||||
Sales and marketing |
1,965 |
|
485 |
|
|
5,264 |
|
1,970 |
|
||||||
Research and development |
9 |
|
28 |
|
|
94 |
|
112 |
|
||||||
General and administrative |
846 |
|
— |
|
|
846 |
|
— |
|
||||||
Other expense (income) |
124 |
|
124 |
|
|
487 |
|
409 |
|
||||||
Provision for income taxes |
(606) |
|
(127) |
|
|
(2,554) |
|
(703) |
|
||||||
Total |
$ |
8,612 |
|
$ |
1,333 |
|
|
$ |
17,289 |
|
$ |
5,136 |
|
||
|
|
|
|
|
|
||||||||||
Acquisition related transaction and integration costs, restructuring charges, and other (1)(2)(3)(4) |
|
|
|
|
|
||||||||||
Cost of sales |
$ |
1,620 |
|
$ |
— |
|
|
$ |
1,626 |
|
$ |
— |
|
||
Sales and marketing |
23,309 |
|
5,356 |
|
|
32,079 |
|
13,646 |
|
||||||
Research and development |
1,184 |
|
3,266 |
|
|
6,374 |
|
4,166 |
|
||||||
General and administrative (1)(4) |
8,685 |
|
2,002 |
|
|
21,279 |
|
11,527 |
|
||||||
Gain on sale of business/asset (1)(2) |
— |
|
— |
|
|
(159,753) |
|
(26,842) |
|
||||||
Other expense (income) |
191 |
|
— |
|
|
589 |
|
— |
|
||||||
Provision for income taxes (3) |
(1,602) |
|
(13,477) |
|
|
32,364 |
|
(12,237) |
|
||||||
Total |
$ |
33,387 |
|
$ |
(2,853) |
|
|
$ |
(65,442) |
|
$ |
(9,740) |
|
||
(1): During the third quarter of 2019, the company recognized a gain of $27 million related to the sale of an office building, presented within "Gain on sale of business/assets". The company also recognized a charitable contribution expense of $7 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative". |
|||||||||||||||
(2): During the first quarter of 2020, we recognized a gain of $160 million related to the divestiture of AWR, presented within "Gain on sale of business/assets". |
|||||||||||||||
(3): During the fourth quarter of 2019, we recognized an income tax benefit of $11 million related to the recognition of deferred taxes on the outside basis difference of our AWR business, which was held-for-sale as of December 31, 2019. |
|||||||||||||||
(4): During the third quarter of 2020, we recognized $5 million of compensation expense related to the replacement of unvested options acquired from OptimalPlus. These amounts were accounted for as post-combination expense and will be recognized over the required service period. |
|||||||||||||||
|
|
|
|
|
|
||||||||||
(Capitalization) and amortization of internally developed software costs |
|
|
|
|
|
||||||||||
Cost of sales |
$ |
6,936 |
|
$ |
7,012 |
|
|
$ |
27,931 |
|
$ |
27,085 |
|
||
Research and development |
(1,248) |
|
(1,887) |
|
|
(4,043) |
|
(9,066) |
|
||||||
Provision for income taxes |
(1,195) |
|
(1,076) |
|
|
(5,017) |
|
(3,784) |
|
||||||
Total |
$ |
4,493 |
|
$ |
4,049 |
|
|
$ |
18,871 |
|
$ |
14,235 |
|
||
|
|
|
|
|
|
National Instruments |
|||||||||||||||
Reconciliation of GAAP to Non-GAAP Measures |
|||||||||||||||
(in thousands, unaudited) |
|||||||||||||||
|
|
|
|
|
|
|
|
||||||||
|
Three Months Ended |
|
Years Ended |
||||||||||||
|
December 31, |
|
December 31, |
||||||||||||
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Reconciliation of Net sales to Non-GAAP Net sales |
|
|
|
|
|
||||||||||
Net sales, as reported |
$ |
367,838 |
|
$ |
367,468 |
|
|
$ |
1,286,671 |
|
$ |
1,353,215 |
|
||
Impact of acquisition related fair value adjustments |
1,961 |
|
— |
|
|
3,260 |
|
— |
|
||||||
Non-GAAP net sales |
$ |
369,799 |
|
$ |
367,468 |
|
|
$ |
1,289,931 |
|
$ |
1,353,215 |
|
||
|
|
|
|
|
|
||||||||||
Reconciliation of Gross Profit to Non-GAAP Gross Profit |
|
|
|
|
|
||||||||||
Gross profit, as reported |
$ |
258,642 |
|
$ |
276,333 |
|
|
$ |
915,550 |
|
$ |
1,016,324 |
|
||
Stock-based compensation |
979 |
887 |
|
3,766 |
3,475 |
||||||||||
Amortization of acquisition-related intangibles and fair value adjustments |
6,274 |
823 |
|
13,152 |
3,348 |
||||||||||
Acquisition transaction and integration costs, restructuring charges and other |
1,620 |
|
— |
|
1,626 |
|
— |
||||||||
Amortization of internally developed software costs |
6,936 |
|
7,012 |
|
|
27,931 |
|
27,085 |
|
||||||
Non-GAAP gross profit |
$ |
274,451 |
|
$ |
285,055 |
|
|
$ |
962,025 |
|
$ |
1,050,232 |
|
||
Non-GAAP gross margin |
74% |
78% |
|
75% |
78% |
||||||||||
|
|
|
|
|
|
||||||||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses |
|
|
|
||||||||||||
Operating expenses, as reported |
$ |
245,186 |
|
$ |
222,652 |
|
|
$ |
875,753 |
|
$ |
868,612 |
|
||
Stock-based compensation |
(14,842) |
|
(12,497) |
|
|
(54,609) |
|
(47,963) |
|
||||||
Amortization of acquisition-related intangibles and fair value adjustments |
(2,820) |
|
(513) |
|
|
(6,204) |
|
(2,082) |
|
||||||
Acquisition transaction and integration costs, restructuring charges and other |
(33,178) |
|
(10,624) |
|
|
(59,732) |
|
(29,339) |
|
||||||
Capitalization of internally developed software costs |
1,248 |
|
1,887 |
|
|
4,043 |
|
9,066 |
|
||||||
Non-GAAP operating expenses |
$ |
195,594 |
|
$ |
200,905 |
|
|
$ |
759,251 |
|
$ |
798,294 |
|
||
|
|
|
|
|
|
||||||||||
Reconciliation of Operating Income to Non-GAAP Operating Income |
|
|
|
||||||||||||
Operating income, as reported |
$ |
13,456 |
|
$ |
53,681 |
|
|
$ |
199,550 |
|
$ |
174,554 |
|
||
Stock-based compensation |
15,821 |
|
13,384 |
|
|
58,375 |
|
51,438 |
|
||||||
Amortization of acquisition-related intangibles and fair value adjustments |
9,094 |
|
1,336 |
|
|
19,356 |
|
5,430 |
|
||||||
Acquisition transaction and integration costs, restructuring charges and other |
34,798 |
|
10,624 |
|
|
61,358 |
|
29,339 |
|
||||||
Net amortization of internally developed software costs |
5,688 |
|
5,125 |
|
|
23,888 |
|
18,019 |
|
||||||
Gain on sale of business/assets |
— |
|
— |
|
|
(159,753) |
|
(26,842) |
|
||||||
Non-GAAP operating income |
$ |
78,857 |
|
$ |
84,150 |
|
|
$ |
202,774 |
|
$ |
251,938 |
|
||
Non-GAAP operating margin |
21% |
23% |
|
16% |
19% |
||||||||||
|
|
|
|
|
|
||||||||||
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes |
|
|
|
||||||||||||
Provision for income taxes, as reported (1) |
$ |
10,515 |
|
$ |
(4,304) |
|
|
$ |
55,103 |
|
$ |
18,393 |
|
||
Stock-based compensation |
445 |
|
1,433 |
|
|
8,705 |
|
9,337 |
|
||||||
Amortization of acquisition-related intangibles and fair value adjustments |
606 |
|
127 |
|
|
2,554 |
|
703 |
|
||||||
Acquisition transaction and integration costs, restructuring charges and other |
1,328 |
|
2,715 |
|
|
4,122 |
|
7,136 |
|
||||||
Net amortization of internally developed software costs |
1,195 |
|
1,076 |
|
|
5,017 |
|
3,784 |
|
||||||
Gain on sale of business/assets |
274 |
|
10,762 |
|
|
(36,486) |
|
5,101 |
|
||||||
Tax reform charge (benefit) |
— |
|
— |
|
|
— |
|
(2,774) |
|
||||||
Non-GAAP provision for income taxes (1) |
$ |
14,363 |
|
$ |
11,809 |
|
|
$ |
39,015 |
|
$ |
41,680 |
|
||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income, Non-GAAP Diluted EPS, and EBITDA |
|||||||||||||||
(in thousands, except per share data, unaudited) |
|||||||||||||||
|
|
|
|
|
|
||||||||||
|
Three Months Ended |
|
Years Ended |
||||||||||||
|
December 31, |
|
December 31, |
||||||||||||
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
|
|
|
|
|
|
||||||||||
Net income, as reported |
$ |
4,738 |
|
$ |
58,596 |
|
|
$ |
143,659 |
|
$ |
162,151 |
|
||
Adjustments to reconcile net income to non-GAAP net income: |
|
|
|
|
|
||||||||||
Stock-based compensation |
15,821 |
|
13,384 |
|
|
58,375 |
|
51,438 |
|
||||||
Amortization of acquisition-related intangibles and fair value adjustments |
9,218 |
|
1,460 |
|
|
19,843 |
|
5,839 |
|
||||||
Acquisition transaction and integration costs, restructuring charges and other |
34,989 |
|
10,624 |
|
|
61,947 |
|
29,339 |
|
||||||
Net amortization of internally developed software costs |
5,688 |
|
5,125 |
|
|
23,888 |
|
18,019 |
|
||||||
Gain on sale of business/asset |
— |
|
— |
|
|
(159,753) |
|
(26,842) |
|
||||||
Income tax effects and adjustments (1) |
(3,848) |
|
(16,113) |
|
|
16,088 |
|
(23,287) |
|
||||||
Non-GAAP net income |
$ |
66,606 |
|
$ |
73,076 |
|
|
$ |
164,047 |
|
$ |
216,657 |
|
||
Non-GAAP net margin |
18.0% |
19.9% |
|
12.7% |
16.0% |
||||||||||
|
|
|
|
|
|
||||||||||
Diluted EPS, as reported |
$ |
0.04 |
|
$ |
0.45 |
|
|
$ |
1.09 |
|
$ |
1.22 |
|
||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS |
|
|
|
|
|
||||||||||
Stock-based compensation |
0.12 |
|
0.10 |
|
|
0.44 |
|
0.39 |
|
||||||
Amortization of acquisition-related intangibles and fair value adjustments |
0.07 |
|
0.01 |
|
|
0.15 |
|
0.04 |
|
||||||
Acquisition transaction and integration costs, restructuring charges and other |
0.27 |
|
0.08 |
|
|
0.47 |
|
0.22 |
|
||||||
Net amortization of internally developed software costs |
0.04 |
|
0.04 |
|
|
0.18 |
|
0.14 |
|
||||||
Gain on sale of business/asset |
— |
|
— |
|
|
(1.21) |
|
(0.20) |
|
||||||
Income tax effects and adjustments (1) |
(0.03) |
|
(0.12) |
|
|
0.12 |
|
(0.18) |
|
||||||
Non-GAAP diluted EPS |
$ |
0.51 |
|
$ |
0.56 |
|
|
$ |
1.24 |
|
$ |
1.63 |
|
||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
|||||||||||||||
|
|
|
|
|
|
||||||||||
Net income, as reported |
$ |
4,738 |
|
$ |
58,596 |
|
|
$ |
143,659 |
|
$ |
162,151 |
|
||
Adjustments to reconcile net income to EBITDA: |
|
|
|
|
|
||||||||||
Interest expense (income), net |
592 |
|
(1,934) |
|
|
(2,016) |
|
(8,089) |
|
||||||
Tax expense (benefit) |
10,515 |
|
(4,304) |
|
|
55,103 |
|
18,393 |
|
||||||
Depreciation and amortization |
25,836 |
|
18,995 |
|
|
87,064 |
|
73,541 |
|
||||||
EBITDA |
$ |
41,681 |
|
$ |
71,353 |
|
|
$ |
283,810 |
|
$ |
245,996 |
|
||
|
|
|
|
|
|
||||||||||
Weighted average shares outstanding |
|
|
|
|
|
||||||||||
Basic |
131,277 |
|
130,776 |
|
|
131,082 |
131,722 |
|
|||||||
Diluted |
131,732 |
|
131,432 |
|
|
131,799 |
132,734 |
|
Reconciliation of GAAP to Non-GAAP Diluted EPS Guidance |
||||||
(unaudited) |
||||||
|
Three Months Ended |
|||||
|
March 31, 2021 |
|||||
|
|
|
||||
|
Low |
High |
||||
GAAP Diluted EPS, guidance |
$ |
(0.05 |
) |
$ |
0.09 |
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS: |
|
|
||||
Stock-based compensation |
0.13 |
|
0.13 |
|
||
Amortization of acquisition-related intangibles and fair value adjustments |
0.06 |
|
0.06 |
|
||
Acquisition transaction and integration costs, restructuring charges and other |
0.12 |
|
0.12 |
|
||
Net amortization of internally developed software costs |
0.05 |
|
0.05 |
|
||
Income tax effects and adjustments (1) |
(0.07 |
) |
(0.07 |
) |
||
Non-GAAP Diluted EPS, guidance |
$ |
0.24 |
|
$ |
0.38 |
|
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
Reconciliation of GAAP Net Sales to Non-GAAP Net Sales, Guidance |
|||||||
(unaudited) |
|||||||
|
Three Months Ended |
|
|||||
|
March 31, |
|
|||||
|
2021 |
2020 |
|
||||
|
(midpoint) |
|
Percent Inc(Dec) |
||||
GAAP Net sales, guidance |
$ |
339,000 |
|
$ |
309,381 |
|
10% |
Impact of purchase accounting fair value adjustments |
1,000 |
|
— |
|
|
||
Non-GAAP Net sales, guidance |
$ |
340,000 |
|
$ |
309,381 |
|
10% |